AMYLIN PHARMACEUTICALS INC Payments for Restructuring
AMYLIN PHARMACEUTICALS INC reported Payments for Restructuring of $7.44 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-08-03.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2012-08-03
- AMYLIN PHARMACEUTICALS INC payments for restructuring for the quarter ending 2012-06-30 was $2.57M.
- AMYLIN PHARMACEUTICALS INC payments for restructuring for the quarter ending 2012-03-31 was $4.87M.
- AMYLIN PHARMACEUTICALS INC payments for restructuring for the quarter ending 2011-12-31 was $23.27M, a 60.14% increase year-over-year.
- AMYLIN PHARMACEUTICALS INC payments for restructuring for the quarter ending 2011-09-30 was -$2.71M.
- AMYLIN PHARMACEUTICALS INC payments for restructuring for fiscal 2011 was $12.83M, a 16.50% decline from fiscal 2010.
- AMYLIN PHARMACEUTICALS INC payments for restructuring for fiscal 2010 was $15.37M.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2012-06-30 | $2.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $7.44M 10-Q · filed 2012-08-03 | $30.71M derived: sum of 3 quarters · filed 2012-08-03 | $28.00M derived: sum of 4 quarters · filed 2012-08-03 |
| 2012-03-31 | $4.87M 10-Q · filed 2012-05-07 | $28.14M derived: sum of 2 quarters · filed 2012-05-07 | $25.43M derived: sum of 3 quarters · filed 2012-05-07 | |
| 2011-12-31 | $23.27M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $20.57M derived: sum of 2 quarters · filed 2012-02-22 | $12.83M 10-K · filed 2012-02-22 | |
| 2011-09-30 | -$2.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | -$10.44M 10-Q · filed 2011-10-28 | ||
| 2011-06-30 | -$7.73M 10-Q · filed 2011-08-08 | |||
| 2010-12-31 | $14.53M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $15.37M 10-K · filed 2012-02-22 | ||
| 2010-09-30 | $833.00K 10-Q · filed 2010-11-08 |